More News
23 March 2021
PhoreMost closes £33M ($46M) Series B financing22 March 2021
SemaThera Enters into a Research Collaboration and Exclusive License Agreement with Roche17 March 2021
Amathus Therapeutics Signs Strategic Collaboration With Merck to Develop Treatments for Neurodegenerative Diseases5 March 2021
ALX Oncology and Tallac Therapeutics Announce Collaboration on Novel Class of Cancer Immunotherapeutics26 February 2021
Roivant Grows Computational Drug Discovery Engine with Acquisition of Silicon Therapeutics25 February 2021
Cullgen Closes $50 Million Series B Investment to Advance Targeted Protein Degraders and Novel E3 Ligands Platform25 February 2021
Merck to Acquire Pandion TherapeuticsNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports